Short description
ev3 is a global technology solutions provider for specialists treating a wide range of vascular diseases and disorders.
Description
ev3 is a global leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons..
With a legacy in technology development and innovation, ev3 is helping endovascular specialists around the world perform more efficiently, effectively and predictably.
ev3. Your endovascular company.
Last funding
Uh Ohhhh
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Plymouth, Minnesota, United States, North America
Founded on
January 1, 2000
Closed on
June 1, 2010
Exited on
April 6, 2005
Went public on
April 6, 2005
Delisted on
July 12, 2010
Stock symbol
EVVV
Non-profit?
No
Acquired?
No
Employees count
1001-5000
Founders
Kumar Surinder